Does DACLATASVIR Cause Diffuse large b-cell lymphoma? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Diffuse large b-cell lymphoma have been filed in association with DACLATASVIR. This represents 0.3% of all adverse event reports for DACLATASVIR.
14
Reports of Diffuse large b-cell lymphoma with DACLATASVIR
0.3%
of all DACLATASVIR reports
0
Deaths
13
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From DACLATASVIR?
Of the 14 reports, 13 (92.9%) required hospitalization.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLATASVIR. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does DACLATASVIR Cause?
Fatigue (510)
Hepatocellular carcinoma (419)
Headache (411)
Hepatitis c (400)
Drug ineffective (385)
Treatment failure (310)
Nausea (287)
Anaemia (251)
Ascites (205)
Off label use (199)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which DACLATASVIR Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
DACLATASVIR vs DACLIZUMAB
DACLATASVIR vs DACOMITINIB
DACLATASVIR vs DACTINOMYCIN
DACLATASVIR vs DALBAVANCIN
DACLATASVIR vs DALFAMPRIDINE